Sbi-Securities-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
4,132
Total Value
2997716131
Accession Number
0001851815-25-000004
Form Type
13F-HR
Manager Name
Sbi-Securities-Co
Data Enrichment
81% identified
3,363 identified769 unidentified

Holdings

4,132 positions • $3.0B total value
Manager:
Search and click to pin securities to the top
Page 177 of 207
NATIONAL BANKSHARES INC
Shares:3
Value:$80
% of Portfolio:0.0% ($80/$3.0B)
ALX ONCOLOGY HOLDINGS INC
Shares:126
Value:$79
% of Portfolio:0.0% ($79/$3.0B)
Vestis Corp
Shares:8
Value:$79
% of Portfolio:0.0% ($79/$3.0B)
TRINET GROUP, INC.
Shares:1
Value:$79
% of Portfolio:0.0% ($79/$3.0B)
Silence Therapeutics plc
Shares:28
Value:$79
% of Portfolio:0.0% ($79/$3.0B)
G4289N205
Shares:57
Value:$78
% of Portfolio:0.0% ($78/$3.0B)
Longeveron Inc.
Shares:50
Value:$78
% of Portfolio:0.0% ($78/$3.0B)
PAVmed Inc.
Shares:108
Value:$78
% of Portfolio:0.0% ($78/$3.0B)
Trinseo PLC
Shares:21
Value:$77
% of Portfolio:0.0% ($77/$3.0B)
EQUIFAX INC
Shares:10
Value:$77
% of Portfolio:0.0% ($77/$3.0B)
BayCom Corp
Shares:3
Value:$76
% of Portfolio:0.0% ($76/$3.0B)
FS Bancorp, Inc.
Shares:2
Value:$76
% of Portfolio:0.0% ($76/$3.0B)
H5870P102
Shares:4
Value:$76
% of Portfolio:0.0% ($76/$3.0B)
Worthington Steel, Inc.
Shares:3
Value:$76
% of Portfolio:0.0% ($76/$3.0B)
25461A544
Shares:4
Value:$76
% of Portfolio:0.0% ($76/$3.0B)
G3016G103
Shares:101
Value:$75
% of Portfolio:0.0% ($75/$3.0B)
Fulcrum Therapeutics, Inc.
Shares:26
Value:$75
% of Portfolio:0.0% ($75/$3.0B)
395330400
Shares:274
Value:$75
% of Portfolio:0.0% ($75/$3.0B)
095633509
Shares:20
Value:$75
% of Portfolio:0.0% ($75/$3.0B)
Shares:33
Value:$75
% of Portfolio:0.0% ($75/$3.0B)